Novel functions of the luteinizing hormone/chorionic gonadotropin receptor in prostate cancer cells and patients
Fig 4
The mean + standard error of the mean of LHCGR concentration in serum is shown for different patient groups, note that it is a log10 scale (A). Localized prostate cancer disease at diagnosis is split in low-, intermediate- and high-risk groups. Each bar represents N = 20 except localized high represented with N = 21 and metastatic and castrate resistant prostate cancer (CRPC) that are represented with N = 18, that are shown as individual dots. Each dot represents a unique patient. Lower panels show cumulative incidence for recurrence in patients that underwent radical prostatectomy (B) or castration (C) as initial treatment. Lines represent the groups that are divided based on LHCGR level being above median measurable LHCGR, below median measurable LHCGR and undetectable LHCGR in serum.